Liver injury related to amoxycillin-clavulanic acid: interlobular bile-duct lesions and extrahepatic manifestations
References (34)
- et al.
Amoxicillin-clavulanate potassium-associated cholestasis
Gastroenterology
(1989) - et al.
Cholestatic hepatitis due to an amoxycillin/clavulanic acid preparation
J Hepatol
(1989) - et al.
Amoxycillin/clavulanic acid induced cholestasis
J Hepatol
(1990) - et al.
Intrahepatic cholestasis following administration of chlorpropamide: report of a case with electron microscopic observations
Am J Med
(1960) - et al.
Granulomatous hepatitis associated with carbamazepine therapy
Am J Med
(1981) - et al.
Barbiturate jaundice: report of a case due to a barbital-containing drug, with positive rechallenge to phenobarbital
Gastroenterology
(1969) Liver cell necrosis in chlorpromazine jaundice (allergic cholangiolitis): a serial study of 26 needle biopsy specimens in nine patients
Am J Med
(1959)- et al.
Liver damage from flucloxacillin, cloxacillin and dicloxacillin
J Hepatol
(1992) - et al.
Antibiotic-associated acute vanishing bile-duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis
J Hepatol
(1994) - et al.
Carbamazepine hepatotoxicity: another cause of the vanishing bile-duct syndrome
Gastroenterology
(1992)
Drug-induced cholestasis
Baillieres Clin Gastroenterol
(1988)
Omeprazole is an aryl hydrocarbon-like inducer of human hepatic cytochrome P450
Gastroenterology
(1990)
Clavulanic acid, a novel inhibitor of β-lactamases
Antimicrob Agents Chemother
(1978)
Cholestatic hepatitis after therapy with amoxicillin/clavulanate potassium
NY State J Med
(1989)
Amoxycillin/clavulanic acid (Augmentin)-induced intrahepatic cholestasis
Dig Dis Sci
(1989)
Cholestatic hepatitis due to antibacterial combination of amoxicillin and clavulanic acid (Augmentin)
Dig Dis Sci
(1989)
Hépatite cholestatique probablement due à l'association d'amoxicilline et d'acide clavulanique
Gastroenterol Clin Biol
(1990)
Cited by (0)
Copyright © 1995 Published by Elsevier Ireland Ltd.